Abstract:Purpose: Acute lymphoblastic leukemia (ALL) is an aggressive hematological cancer with limited therapeutic options for adult patients. Aurora kinases have drawn attention as potential targets in hematological neoplasms due to their high expression and biological functions. Aurora kinase A (AURKA) and AURKB are essential for a successful mitosis, acting in spindle mitotic organization and cytokinesis. Reversine is a synthetic purine analog that acts as a multi-kinase inhibitor with anti-neoplastic activity by targeting AURKA and AURKB. Methods: ALL patient gene expression data were retrieved from the Amazonia! Database: For functional assays, Jurkat (T-ALL) and Namalwa (B-ALL) cells were exposed to increasing concentrations of reversine and submitted to various cellular and molecular assays. Results: We found that AURKB expression was higher in ALL patient samples compared to normal lymphocytes (p < 0.0001). The ALL cell lines tested displayed aberrant AURKA and AURKB expression. In Jurkat and Namalwa cells, reversine reduced cell viability in a dose- and time-dependent manner (p < 0.05). Reversine also significantly reduced the viability of primary ALL cells. Reversine induced apoptosis and autophagy, and reduced cell proliferation in both cell lines (p < 0.05). Mitotic catastrophe markers, including cell cycle arrest at G2/M, increased cell size and DNA damage, were observed upon reversine exposure. Short- and long-term treatment with reversine inhibited autonomous clonogenicity (p < 0.05). At the molecular level, reversine reduced AURKB activity, induced SQSTM1/p62 consumption, and increased LC3BII and γ-H2AX levels. In Namalwa cells, reversine modulated 25 out of 84 autophagy-related genes, including BCL2, BAD, ULK1, ATG10, IRGM and MAP1LC3B, which indicates that reversine acts by initiating and sustaining autophagy signals in ALL cells. Conclusions: From our data we conclude that reversine reduces the viability of ALL cells by triggering multiple cell death mechanisms, including apoptosis, mitotic catastrophe, and autophagy. Our findings highlight reversine as a potential anticancer agent for ALL.

Reversine induces cell cycle arrest, polyploidy, and apoptosis in human breast cancer cells

Salidroside Induces Cell-Cycle Arrest and Apoptosis in Human Breast Cancer Cells

Reversine, a Substituted Purine, Exerts an Inhibitive Effect on Human Renal Carcinoma Cells Via Induction of Cell Apoptosis and Polyploidy

Effect of Proliferation, Cell Cycle, and Bcl-2s of MCF-7 Cells by Resveratrol

Bexarotene: a Promising Anticancer Agent

Pterostilbene Simultaneously Induces Apoptosis, Cell Cycle Arrest and Cyto-Protective Autophagy in Breast Cancer Cells.

Supplementary Figure 2 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia

[Reversal Effect of Resveratrol on Chemotherapy Resistance in KBv200 Cell Line and Underlying Mechanisms].

Targeting glioma cells by antineoplastic activity of reversine

Co-treatment with miR-21-5p inhibitor and Aurora kinase inhibitor reversine suppresses breast cancer progression by targeting sprouty RTK signaling antagonist 2

Supplementary Table 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure 3 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

Reversal Effect of Resveratrol on Multidrug Resistance in KBv200 Cell Line

Small-molecule inducer of cancer cell polyploidy promotes apoptosis or senescence: Implications for therapy

Resveratrol Treatment Inhibits Proliferation of and Induces Apoptosis in Human Colon Cancer Cells

Resveratrol Induces Apoptosis and Cell Cycle Arrest of Human T24 Bladder Cancer Cells in Vitro and Inhibits Tumor Growth in Vivo

P53 INDEPENDENT G(0)/G(1) ARREST AND APOPTOSIS INDUCED BY A NOVEL RETINOID IN HUMAN BREAST-CANCER CELLS

Resveratrol confers resistance against taxol via induction of cell cycle arrest in human cancer cell lines.

A Resveratrol Analog, Phoyunbene B, Induces G2/M Cell Cycle Arrest and Apoptosis in HepG2 Liver Cancer Cells.